Sernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases. The company develops Cell Pouch System, an implantable medical device, which offers a natural organ-like environment for the long-term survival and function of insulin producing islets for the treatment of diabetes. Sernova uses proprietary local immune protection technologies that protect therapeutic cells within the Cell Pouch from the attack of immune system. Its major pipeline products include human donor islets, microencapsulated islets; microencapsulated stem cell derived cells; corrected patient cells; allograft immune protected cells; and autograft thyroid cells. The company’s product portfolio addresses metabolic diseases such as insulin dependent diabetes, thyroid problems, blood disorders such as hemophilia A and other diseases. Sernova is headquartered in London, Ontario, Canada.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sernova Biotherapeutics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Sernova Biotherapeutics Inc Company Overview
- Sernova Biotherapeutics Inc Company Snapshot
- Sernova Biotherapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Sernova Biotherapeutics Inc - Pipeline Analysis Overview
- Business Description
- Sernova Biotherapeutics Inc - Key Facts
- Sernova Biotherapeutics Inc - Major Products and Services
- Sernova Biotherapeutics Inc Pipeline Products by Development Stage
- Sernova Biotherapeutics Inc Ongoing Clinical Trials by Trial Status
- Sernova Biotherapeutics Inc Pipeline Products Overview
- Cell Pouch System - Hemophilia
- Cell Pouch System - Hemophilia Product Overview
- Cell Pouch System - Hemophilia Allograft Immune Protected Cells
- Cell Pouch System - Hemophilia Allograft Immune Protected Cells Product Overview
- Cell Pouch System - Microencapsulated Islets
- Cell Pouch System - Microencapsulated Islets Product Overview
- Cell Pouch System - Microencapsulated Stem Cell Derived Cells
- Cell Pouch System - Microencapsulated Stem Cell Derived Cells Product Overview
- Cell Pouch System - Thyroid Disease
- Cell Pouch System - Thyroid Disease Product Overview
- Cell Pouch System - Type 1 Diabetes Mellitus
- Cell Pouch System - Type 1 Diabetes Mellitus Product Overview
- Cell Pouch System - Type 1 Diabetes Mellitus Clinical Trial
- Sernova Biotherapeutics Inc - Key Competitors
- Sernova Biotherapeutics Inc - Key Employees
- Sernova Biotherapeutics Inc - Key Employee Biographies
- Sernova Biotherapeutics Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Sernova Biotherapeutics Inc, Recent Developments
- May 14, 2025: Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes
- Apr 15, 2025: Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
- Apr 01, 2025: Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch Bio-Hybrid Organ for Treatment of Type 1 Diabetes
- Mar 03, 2025: Sernova Biotherapeutics Receives FDA Clearance for IND Application for Its Cell Pouch Bio-Hybrid Organ With Autograft Thyroid Cells in Patients With Hypothyroidism
- Dec 02, 2024: Sernova Update on Strategic Initiatives
- Oct 11, 2024: Sernova Announces Key New Executive Appointments
- Oct 03, 2024: Sernova to Present at the 2024 Cell & Gene Meeting on the Mesa
- Sep 12, 2024: Sernova Announces New Positive Data From Phase I/II Trial Regarding Islet Survival and Function
- Jun 25, 2024: Sernova Announces Additional Patient Insulin Independent and Cohort 2 Enrollment Complete in Ongoing Phase I/II Clinical Trial for Treatment of Type 1 Diabetes
- Apr 02, 2024: Sernova Provides Positive Clinical and Platform Portfolio Update
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Sernova Biotherapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Sernova Biotherapeutics Inc Pipeline Products by Equipment Type
- Sernova Biotherapeutics Inc Pipeline Products by Indication
- Sernova Biotherapeutics Inc Ongoing Clinical Trials by Trial Status
- Sernova Biotherapeutics Inc, Key Facts
- Sernova Biotherapeutics Inc, Major Products and Services
- Sernova Biotherapeutics Inc Number of Pipeline Products by Development Stage
- Sernova Biotherapeutics Inc Pipeline Products Summary by Development Stage
- Sernova Biotherapeutics Inc Ongoing Clinical Trials by Trial Status
- Sernova Biotherapeutics Inc Ongoing Clinical Trials Summary
- Cell Pouch System - Hemophilia - Product Status
- Cell Pouch System - Hemophilia - Product Description
- Cell Pouch System - Hemophilia Allograft Immune Protected Cells - Product Status
- Cell Pouch System - Hemophilia Allograft Immune Protected Cells - Product Description
- Cell Pouch System - Microencapsulated Islets - Product Status
- Cell Pouch System - Microencapsulated Islets - Product Description
- Cell Pouch System - Microencapsulated Stem Cell Derived Cells - Product Status
- Cell Pouch System - Microencapsulated Stem Cell Derived Cells - Product Description
- Cell Pouch System - Thyroid Disease - Product Status
- Cell Pouch System - Thyroid Disease - Product Description
- Cell Pouch System - Type 1 Diabetes Mellitus - Product Status
- Cell Pouch System - Type 1 Diabetes Mellitus - Product Description
- Cell Pouch System - Type 1 Diabetes Mellitus - A Phase I/II First-in-human of Cell Pouch Device for the Treatment of Patients with T1D and Severe Hypoglycemia
- Cell Pouch System - Type 1 Diabetes Mellitus - A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch for Clinical Islet Transplantation
- Sernova Corp, Key Employees
- Sernova Biotherapeutics Inc, Key Employee Biographies
- Glossary
- Sernova Biotherapeutics Inc Pipeline Products by Equipment Type
- Sernova Biotherapeutics Inc Pipeline Products by Development Stage
- Sernova Biotherapeutics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ConjuChem LLC
- Sigilon Therapeutics Inc
- Semma Therapeutics Inc
- AstraZeneca Plc
- Alnara Pharmaceuticals Inc
- Diamyd Medical AB
